Experiences of coordinated care for people in the UK affected by rare diseases: cross-sectional survey of patients, carers, and healthcare professionals.

Care coordination Care coordinator Care plan Rare conditions Rare diseases Specialist centre Survey

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
23 Nov 2023
Historique:
received: 28 06 2023
accepted: 25 09 2023
medline: 27 11 2023
pubmed: 24 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

Poorly coordinated care can have major impacts on patients and families affected by rare conditions, with negative physical health, psychosocial and financial consequences. This study aimed to understand how care is coordinated for rare diseases in the United Kingdom. We undertook a national survey in the UK involving 760 adults affected by rare diseases, 446 parents/carers of people affected by rare diseases, and 251 healthcare professionals who care for people affected by rare diseases. Findings suggested that a wide range of patients, parents and carers do not have coordinated care. For example, few participants reported having a care coordinator (12% patients, 14% parents/carers), attending a specialist centre (32% patients, 33% parents/carers) or having a care plan (10% patients, 44% parents/carers). A very small number of patients (2%) and parents/carers (5%) had access to all three-a care coordinator, specialist centre and care plan. Fifty four percent of patients and 33% of parents/carers reported access to none of these. On the other hand, a higher proportion of healthcare professionals reported that families with rare conditions had access to care coordinators (35%), specialist centres (60%) and care plans (40%). Care for families with rare conditions is generally not well coordinated in the UK, with findings indicating limited access to care coordinators, specialist centres and care plans. Better understanding of these issues can inform how care coordination might be improved and embrace the needs and preferences of patients and families affected by rare conditions.

Sections du résumé

BACKGROUND BACKGROUND
Poorly coordinated care can have major impacts on patients and families affected by rare conditions, with negative physical health, psychosocial and financial consequences. This study aimed to understand how care is coordinated for rare diseases in the United Kingdom.
METHODS METHODS
We undertook a national survey in the UK involving 760 adults affected by rare diseases, 446 parents/carers of people affected by rare diseases, and 251 healthcare professionals who care for people affected by rare diseases.
RESULTS RESULTS
Findings suggested that a wide range of patients, parents and carers do not have coordinated care. For example, few participants reported having a care coordinator (12% patients, 14% parents/carers), attending a specialist centre (32% patients, 33% parents/carers) or having a care plan (10% patients, 44% parents/carers). A very small number of patients (2%) and parents/carers (5%) had access to all three-a care coordinator, specialist centre and care plan. Fifty four percent of patients and 33% of parents/carers reported access to none of these. On the other hand, a higher proportion of healthcare professionals reported that families with rare conditions had access to care coordinators (35%), specialist centres (60%) and care plans (40%).
CONCLUSIONS CONCLUSIONS
Care for families with rare conditions is generally not well coordinated in the UK, with findings indicating limited access to care coordinators, specialist centres and care plans. Better understanding of these issues can inform how care coordination might be improved and embrace the needs and preferences of patients and families affected by rare conditions.

Identifiants

pubmed: 37996938
doi: 10.1186/s13023-023-02934-9
pii: 10.1186/s13023-023-02934-9
pmc: PMC10668407
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

364

Subventions

Organisme : Health Services and Delivery Research Programme
ID : 16/116/82

Informations de copyright

© 2023. The Author(s).

Références

Orphanet J Rare Dis. 2022 Apr 20;17(1):171
pubmed: 35443702
Int J Integr Care. 2020 Jun 25;20(2):14
pubmed: 32607101
Psychiatr Serv. 2000 Nov;51(11):1410-21
pubmed: 11058189
Orphanet J Rare Dis. 2015 Nov 24;10:149
pubmed: 26603037
Orphanet J Rare Dis. 2022 Feb 14;17(1):49
pubmed: 35164822
Orphanet J Rare Dis. 2016 Mar 24;11:30
pubmed: 27012247
Hosp Pediatr. 2020 Aug;10(8):687-693
pubmed: 32641383
Child Care Health Dev. 1997 Jan;23(1):29-40
pubmed: 9023029
Orphanet J Rare Dis. 2021 Feb 10;16(1):76
pubmed: 33568181
J Am Med Inform Assoc. 2017 Sep 01;24(5):933-941
pubmed: 28371887
Eur J Hum Genet. 2020 Feb;28(2):165-173
pubmed: 31527858

Auteurs

Holly Walton (H)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK. holly.walton@ucl.ac.uk.

Pei Li Ng (PL)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.

Amy Simpson (A)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.
Genetic Alliance UK, Creative Works, 7 Blackhorse Lane, London, E17 6DS, UK.

Lara Bloom (L)

The Ehlers-Danlos Society and Academic Affiliate Professor of Practice in Patient Engagement and Global Collaboration (Penn State College of Medicine), Hershey, USA.

Lyn S Chitty (LS)

North Thames Genomic Laboratory Hub, Great Ormond Street NHS Foundation Trust, London, UK.
UCL Great Ormond Street Institute of Child Health, London, UK.

Naomi J Fulop (NJ)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.

Amy Hunter (A)

Genetic Alliance UK, Creative Works, 7 Blackhorse Lane, London, E17 6DS, UK.

Jennifer Jones (J)

Genetic Alliance UK, Creative Works, 7 Blackhorse Lane, London, E17 6DS, UK.

Joe Kai (J)

Division of Primary Care, Centre for Academic Primary Care, NIHR School for Primary Care Research, University of Nottingham, Floors 13-15, Tower Building, University Park, Nottingham, NG7 2RD, UK.

Larissa Kerecuk (L)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
NIHR Clinical Research Network West Midlands, Birmingham, UK.

Maria Kokocinska (M)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Kerry Leeson-Beevers (K)

Alstrom Syndrome UK, 4 St Kitts Close, Torquay, TQ2 7GD, Devon, UK.

Sharon Parkes (S)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

Angus I G Ramsay (AIG)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.

Alastair Sutcliffe (A)

UCL and Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Christine Taylor (C)

Department of Applied Health Research, University College London, Gower Street, London, WC1E 6BT, UK.

Stephen Morris (S)

Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH